Lundell L - Search Results

1

Is the esophageal squamous epithelial barrier function impaired in patients with gastroesophageal reflux disease?

Carlsson R, Fändriks L, Jönsson C, Lundell L, Orlando RC. Carlsson R, et al. Among authors: lundell l. Scand J Gastroenterol. 1999 May;34(5):454-8. doi: 10.1080/003655299750026155. Scand J Gastroenterol. 1999. PMID: 10423058 Clinical Trial.

2

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.

Sandmark S, Carlsson R, Fausa O, Lundell L. Sandmark S, et al. Among authors: lundell l. Scand J Gastroenterol. 1988 Jun;23(5):625-32. doi: 10.3109/00365528809093923. Scand J Gastroenterol. 1988. PMID: 3041558 Clinical Trial.

3

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Carlsson R, Dent J, Bolling-Sternevald E, Johnsson F, Junghard O, Lauritsen K, Riley S, Lundell L. Carlsson R, et al. Among authors: lundell l. Scand J Gastroenterol. 1998 Oct;33(10):1023-9. doi: 10.1080/003655298750026697. Scand J Gastroenterol. 1998. PMID: 9829354

4

Actions by angiotensin II on esophageal contractility in humans.

Casselbrant A, Edebo A, Wennerblom J, Lönroth H, Helander HF, Vieth M, Lundell L, Fändriks L. Casselbrant A, et al. Among authors: lundell l. Gastroenterology. 2007 Jan;132(1):249-60. doi: 10.1053/j.gastro.2006.11.010. Epub 2006 Nov 10. Gastroenterology. 2007. PMID: 17241875 Clinical Trial.

5

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response.

Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, Junghard O, Lauritsen K, Lundell L, Pedersen SA, Stubberöd A. Lind T, et al. Among authors: lundell l. Scand J Gastroenterol. 1997 Oct;32(10):974-9. doi: 10.3109/00365529709011212. Scand J Gastroenterol. 1997. PMID: 9361168 Clinical Trial.

6

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial.

Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen SA, Anker-Hansen O, Stubberöd A, Eriksson G, Carlsson R, Junghard O. Lind T, et al. Among authors: lundell l. Aliment Pharmacol Ther. 1999 Jul;13(7):907-14. doi: 10.1046/j.1365-2036.1999.00564.x. Aliment Pharmacol Ther. 1999. PMID: 10383525 Clinical Trial.

7

Sources of intra-oesophageal nitric oxide production following intraluminal acid exposure.

Casselbrant A, Pettersson A, Ruth M, Bove M, Lundell L, Fändriks L. Casselbrant A, et al. Among authors: lundell l. Scand J Gastroenterol. 2002 Jun;37(6):631-7. doi: 10.1080/00365520212497. Scand J Gastroenterol. 2002. PMID: 12126238

8

The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis.

Ruth M, Enbom H, Lundell L, Lönroth H, Sandberg N, Sandmark S. Ruth M, et al. Among authors: lundell l. Scand J Gastroenterol. 1988 Nov;23(9):1141-6. doi: 10.3109/00365528809090182. Scand J Gastroenterol. 1988. PMID: 3073525 Clinical Trial.

9

Long-term treatment of gastro-oesophageal reflux disease with omeprazole.

Lundell L. Lundell L. Scand J Gastroenterol Suppl. 1994;201:74-8. doi: 10.3109/00365529409105368. Scand J Gastroenterol Suppl. 1994. PMID: 8047829 Review.

10

Is motility impaired in the entire upper gastrointestinal tract in patients with gastro-oesophageal reflux disease?

Lundell L, Myers JC, Jamieson GG. Lundell L, et al. Scand J Gastroenterol. 1996 Feb;31(2):131-5. doi: 10.3109/00365529609031976. Scand J Gastroenterol. 1996. PMID: 8658034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters